Ana M. Matos

548 total citations
22 papers, 429 citations indexed

About

Ana M. Matos is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Ana M. Matos has authored 22 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Organic Chemistry. Recurrent topics in Ana M. Matos's work include Alzheimer's disease research and treatments (4 papers), Computational Drug Discovery Methods (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Ana M. Matos is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Computational Drug Discovery Methods (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Ana M. Matos collaborates with scholars based in Portugal, Spain and Italy. Ana M. Matos's co-authors include Amélia P. Rauter, José M. Andrade, Cecília M. Arraiano, Vânia Pobre, Maria Paula Macedo, Catarina Dias, Maria‐José U. Ferreira, Noélia Duarte, Mariana Reis and J.M.F. Nogueira and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Ana M. Matos

22 papers receiving 421 citations

Peers

Countries citing papers authored by Ana M. Matos

Since Specialization

Citations

This map shows the geographic impact of Ana M. Matos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana M. Matos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana M. Matos more than expected).

Fields of papers citing papers by Ana M. Matos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana M. Matos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana M. Matos. The network helps show where Ana M. Matos may publish in the future.

Co-authorship network of co-authors of Ana M. Matos

This figure shows the co-authorship network connecting the top 25 collaborators of Ana M. Matos. A scholar is included among the top collaborators of Ana M. Matos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana M. Matos. Ana M. Matos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alkyl deoxyglycoside-polymyxin combinations against critical priority carbapenem-resistant gram-negative bacteria 2024 ·Scientific Reports ·Ana M. Matos, (unknown), (unknown), Rita M. C. de Almeida, Amélia P. Rauter, M. Conceição Oliveira, Vera Manageiro, Manuela Caniça	1
2	Recent antibacterial carbohydrate-based prodrugs, drugs and delivery systems to overcome antimicrobial resistance 2024 ·Current Opinion in Chemical Biology ·(unknown), Ana M. Matos, Amélia P. Rauter	10
3	Antibacterial Prodrugs to Overcome Bacterial Antimicrobial Resistance 2024 ·Pharmaceuticals ·(unknown), Ana M. Matos, Amélia P. Rauter	4
4	The (Poly)phenol-Carbohydrate Combination for Diabetes: Where Do We Stand? 2023 ·Nutrients ·Ana M. Matos, Regina Menezes	2
5	Recent Advances in the Development and Synthesis of Carbohydrate‐Based Molecules with Promising Antibacterial Activity 2022 ·European Journal of Organic Chemistry ·Ana M. Matos	13
6	C-Glucosylation as a tool for the prevention of PAINS-induced membrane dipole potential alterations 2021 ·Scientific Reports ·Ana M. Matos, (unknown), Carla Sousa, M. Conceição Oliveira, Rodrigo F.M. de Almeida, Amélia P. Rauter	15
7	Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer 2020 ·Frontiers in Pharmacology ·Mariana Reis, Ana M. Matos, Noélia Duarte, (unknown), Ricardo J. Ferreira, Hermann Lage, Maria‐José U. Ferreira	18
8	Design and Synthesis of CNS-targeted Flavones and Analogues with Neuroprotective Potential Against H2O2- and Aβ1-42-Induced Toxicity in SH-SY5Y Human Neuroblastoma Cells 2019 ·Pharmaceuticals ·Ana M. Matos, Alice Martins, (unknown), David A. Evans, Magnus W. Walter, M. Conceição Oliveira, Óscar López, José G. Fernández‐Bolaños, (unknown), Beat Ernst, Maria Paula Macedo, Marialessandra Contino, Nicola Antonio Colabufo, Amélia P. Rauter	11
9	Discovery of N-methylpiperazinyl flavones as a novel class of compounds with therapeutic potential against Alzheimer’s disease: synthesis, binding affinity towards amyloid β oligomers (Aβo) and ability to disrupt Aβo-PrP^C interactions 2019 ·Pure and Applied Chemistry ·Ana M. Matos, (unknown), (unknown), Cleide Dos Santos Souza, Emma Mead, (unknown), (unknown), Maria Cristina Oliveira, David A. Evans, (unknown), Benjamin M. Partridge, Claire J. Garwood, Ke Ning, Gary J. Sharman, Beining Chen, Amélia P. Rauter	11
10	Synthesis and effects of flavonoid structure variation on amyloid-β aggregation 2017 ·Pure and Applied Chemistry ·Ana M. Matos, Joana S. Cristóvão, Dmitry V. Yashunsky, Nikolay E. Nifantiev, Ana S. Viana, Cláudio M. Gomes, Amélia P. Rauter	13
11	Computational model for power optimization of piezoelectric vibration energy harvesters with material homogenization 2017 ·Computers & Structures ·Ana M. Matos, J. M. Guedes, K. P. Jayachandran, H. C. Rodrigues	12
12	Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential 2017 ·Medicinal Research Reviews ·Ana M. Matos, Maria Paula Macedo, Amélia P. Rauter	53
13	Exploring Anti-Prion Glyco-Based and Aromatic Scaffolds: A Chemical Strategy for the Quality of Life 2017 ·Molecules ·(unknown), Ana M. Matos, Amélia P. Rauter	12
14	Isololiolide, a carotenoid metabolite isolated from the brown alga Cystoseira tamariscifolia, is cytotoxic and able to induce apoptosis in hepatocarcinoma cells through caspase-3 activation, decreased Bcl-2 levels, increased p53 expression and PARP cleavage 2016 ·Phytomedicine ·Catarina Vizetto‐Duarte, Luísa Custódio, Katkam N. Gangadhar, João Henrique G. Lago, Catarina Dias, Ana M. Matos, Nuno R. Neng, J.M.F. Nogueira, Luísa Barreira, Fernando Alberício, Amélia P. Rauter, João Varela	59
15	<strong>Design and synthesis of CNS-targeted drug-like flavonoid analogues with potential against Alzheimer’s disease and type 2 diabetes</strong> 2016 ·Amélia P. Rauter, Ana M. Matos	1
16	Epoxylathyrol Derivatives: Modulation of ABCB1-Mediated Multidrug Resistance in Human Colon Adenocarcinoma and Mouse T-Lymphoma Cells 2015 ·Journal of Natural Products ·Ana M. Matos, Mariana Reis, Noélia Duarte, Gabriella Spengler, Joséph Molnár, Maria‐José U. Ferreira	29
17	Exploiting the Therapeutic Potential of 8-β-d-Glucopyranosylgenistein: Synthesis, Antidiabetic Activity, and Molecular Interaction with Islet Amyloid Polypeptide and Amyloid β-Peptide (1–42) 2014 ·Journal of Medicinal Chemistry ·Ana Rita Jesus, Catarina Dias, Ana M. Matos, Rodrigo F.M. de Almeida, Ana S. Viana, Filipa Marcelo, Rogério T. Ribeiro, Maria Paula Macedo, Cristina Airoldi, Francesco Nicotra, Alice Martins, Eurico J. Cabrita, Jesús Jiménez‐Barbero, Amélia P. Rauter	35
18	Targets, Structures, and Recent Approaches in Malignant Melanoma Chemotherapy 2013 ·ChemMedChem ·Ana M. Matos, Ana Paula Francisco	7
19	The crucial role of PNPase in the degradation of small RNAs that are not associated with Hfq 2012 ·RNA ·José M. Andrade, Vânia Pobre, Ana M. Matos, Cecília M. Arraiano	91
20	Acute exercise reverses TRB3 expression in the skeletal muscle and ameliorates whole body insulin sensitivity in diabetic mice 2009 ·Acta Physiologica ·Ana M. Matos, Eduardo R. Ropelle, José Rodrigo Pauli, Marisa Jádna Silva Frederico, Ricardo A. Pinho, Lı́cio A. Velloso, Cláudio Teodoro de Souza	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact